Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

18 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Human skin permeation of Delta8-tetrahydrocannabinol, cannabidiol and cannabinol.
Stinchcomb AL, Valiveti S, Hammell DC, Ramsey DR. Stinchcomb AL, et al. Among authors: valiveti s. J Pharm Pharmacol. 2004 Mar;56(3):291-7. doi: 10.1211/0022357022791. J Pharm Pharmacol. 2004. PMID: 15025853
Cannabidiol bioavailability after nasal and transdermal application: effect of permeation enhancers.
Paudel KS, Hammell DC, Agu RU, Valiveti S, Stinchcomb AL. Paudel KS, et al. Among authors: valiveti s. Drug Dev Ind Pharm. 2010 Sep;36(9):1088-97. doi: 10.3109/03639041003657295. Drug Dev Ind Pharm. 2010. PMID: 20545522
Permeation of WIN 55,212-2, a potent cannabinoid receptor agonist, across human tracheo-bronchial tissue in vitro and rat nasal epithelium in vivo.
Agu RU, Valiveti S, Paudel KS, Klausner M, Hayden PJ, Stinchcomb AL. Agu RU, et al. Among authors: valiveti s. J Pharm Pharmacol. 2006 Nov;58(11):1459-65. doi: 10.1211/jpp.58.11.0006. J Pharm Pharmacol. 2006. PMID: 17132208
Intranasal absorption of Delta(9)-tetrahydrocannabinol and WIN55,212-2 mesylate in rats.
Valiveti S, Agu RU, Hammell DC, Paudel KS, Earles DC, Wermeling DP, Stinchcomb AL. Valiveti S, et al. Eur J Pharm Biopharm. 2007 Feb;65(2):247-52. doi: 10.1016/j.ejpb.2006.08.009. Epub 2006 Aug 23. Eur J Pharm Biopharm. 2007. PMID: 17014999
Transdermal delivery of naltrexone and its active metabolite 6-beta-naltrexol in human skin in vitro and guinea pigs in vivo.
Paudel KS, Nalluri BN, Hammell DC, Valiveti S, Kiptoo P, Hamad MO, Crooks PA, Stinchcomb AL. Paudel KS, et al. Among authors: valiveti s. J Pharm Sci. 2005 Sep;94(9):1965-75. doi: 10.1002/jps.20398. J Pharm Sci. 2005. PMID: 16052561
In vitro/in vivo correlation of transdermal naltrexone prodrugs in hairless guinea pigs.
Valiveti S, Paudel KS, Hammell DC, Hamad MO, Chen J, Crooks PA, Stinchcomb AL. Valiveti S, et al. Pharm Res. 2005 Jun;22(6):981-9. doi: 10.1007/s11095-005-4593-0. Epub 2005 Jun 8. Pharm Res. 2005. PMID: 15948042
LC-MS method for the estimation of delta8-THC and 11-nor-delta8-THC-9-COOH in plasma.
Valiveti S, Hammell DC, Earles DC, Stinchcomb AL. Valiveti S, et al. J Pharm Biomed Anal. 2005 Jun 1;38(1):112-8. doi: 10.1016/j.jpba.2004.11.055. Epub 2005 Jan 5. J Pharm Biomed Anal. 2005. PMID: 15907628
In vivo evaluation of 3-O-alkyl ester transdermal prodrugs of naltrexone in hairless guinea pigs.
Valiveti S, Hammell DC, Paudel KS, Hamad MO, Crooks PA, Stinchcomb AL. Valiveti S, et al. J Control Release. 2005 Feb 2;102(2):509-20. doi: 10.1016/j.jconrel.2004.10.005. J Control Release. 2005. PMID: 15653167
Intranasal delivery of recombinant human parathyroid hormone [hPTH (1-34)], teriparatide in rats.
Agu RU, Valiveti S, Earles DC, Klausner M, Hayden PJ, Wermeling DP, Stinchcomb AL. Agu RU, et al. Among authors: valiveti s. Endocr Res. 2004 Aug;30(3):455-67. doi: 10.1081/erc-200035957. Endocr Res. 2004. PMID: 15554361
Transdermal delivery of the synthetic cannabinoid WIN 55,212-2: in vitro/in vivo correlation.
Valiveti S, Hammell DC, Earles DC, Stinchcomb AL. Valiveti S, et al. Pharm Res. 2004 Jul;21(7):1137-45. doi: 10.1023/b:pham.0000032999.31948.2e. Pharm Res. 2004. PMID: 15290852
18 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback